CIK 0001506251 · Non-accelerated filer<br>Smaller reporting company
Citius Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CTXR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273425913
- Phone
- (908) 967-6676
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- Trail One, Inc., TrailOne, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-13 | HOLUBIAK MYRON Z President and CEO | Grant or award · Warrant to Purchase Common Stock | +784,314 | 784,314 | ||
| 2018-03-29 | Mazur Leonard L Executive Chairman | Purchase | +167,504 | $2.99 | $500K | 3,718,340 |
| 2018-03-29 | Mazur Leonard L Executive Chairman | Purchase · Warrant to Purchase Common Stock | +167,504 | 167,504 | ||
| 2018-03-28 | HOLUBIAK MYRON Z President and CEO | Purchase | +2,915 | $3.09 | $9K | 519,882 |
| 2017-12-19 | Mazur Leonard L Executive Chairman | Purchase | +213,106 | $4.69 | $999K | 3,550,836 |
| 2017-09-15 | Mazur Leonard L Executive Chairman | Grant or award · Options to Purchase Common Stock | +40,000 | 40,000 | ||
| 2017-09-15 | HOLUBIAK MYRON Z President and CEO | Grant or award · Options to Purchase Common Stock | +40,000 | 40,000 | ||
| 2017-09-15 | Dutia Suren G Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2017-09-15 | Kane William Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2017-09-15 | Webb Carol Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2017-09-15 | SAFIR HOWARD Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2017-09-15 | Holuka Eugene Myron Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2017-08-24 | Mazur Leonard L Executive Chairman | Purchase | +11,000 | $2.68 | $29K | 3,337,730 |
| 2017-08-24 | Mazur Leonard L Executive Chairman | Purchase · Warrant to Purchase Common Stock | +11,000 | $0.54 | $6K | 11,000 |
| 2017-08-08 | Mazur Leonard L Executive Chairman | Purchase | +421,400 | $4.13 | $1.7M | 1,779,663 |
| 2017-08-08 | Mazur Leonard L Executive Chairman | Conversion | +1,547,067 | $3.09 | $4.8M | 3,326,730 |
| 2017-08-08 | Mazur Leonard L Executive Chairman | Purchase · Warrant to Purchase Common Stock | +421,400 | $0.01 | $4K | 421,400 |
| 2017-08-08 | Mazur Leonard L Executive Chairman | Grant or award · Convertible Promissory Note | +1,547,067 | 1,547,067 | ||
| 2017-08-08 | Mazur Leonard L Executive Chairman | Conversion · Convertible Promissory Note | −1,547,067 | 0 | ||
| 2016-06-23 | Holuka Eugene Myron Director | Grant or award · Options to Purchase Common Stock | +200,000 | $0.80 | $160K | 200,000 |
Page 7 of 8 · 156 trades